Application Nr Approved Date Route Status External Links
NDA208261 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Zepatier ® Is Indicated For The Treatment Of Chronic Hepatitis C Virus (Hcv) Genotype 1 Or 4 Infection In Adults. Zepatier Is Indicated For Use With Ribavirin In Certain Patient Populations [See Dosage And Administration (2.2) ] . Zepatier Is A Fixed-Dose Combination Product Containing Elbasvir, A Hepatitis C Virus (Hcv) Ns5a Inhibitor, And Grazoprevir, An Hcv Ns3/4a Protease Inhibitor, And Is Indicated For Treatment Of Chronic Hcv Genotype 1 Or 4 Infection In Adults. Zepatier Is Indicated For Use With Ribavirin In Certain Patient Populations. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 2 Total)

Name Structure ZINC ID(s)
1. Elbasvir ELBASVIR ZINC150588351
2. Grazoprevir Anhydrous

Comments